Found: 23
Select item for more details and to access through your institution.
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myeloma.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Perioperative treatment with filgrastim stimulates granulocyte function and reduces infectious complications after esophagectomy.
- Published in:
- 2000
- By:
- Publication type:
- journal article
The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
BAYESIAN DECISION THRESHOLD, DETECTION LIMIT AND CONFIDENCE LIMITS IN IONISING-RADIATION MEASUREMENT.
- Published in:
- Radiation Protection Dosimetry, 2006, v. 121, n. 1, p. 52, doi. 10.1093/rpd/ncl095
- By:
- Publication type:
- Article
Morbus Castleman in der rheumatologischen Praxis.
- Published in:
- Zeitschrift für Rheumatologie, 2024, v. 83, n. 4, p. 316, doi. 10.1007/s00393-023-01393-8
- By:
- Publication type:
- Article
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 865, doi. 10.1038/bmt.2014.39
- By:
- Publication type:
- Article
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 8, p. 1046, doi. 10.1038/bmt.2011.216
- By:
- Publication type:
- Article
Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 7, p. 1003, doi. 10.1038/bmt.2011.199
- By:
- Publication type:
- Article
Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 8, p. 1045, doi. 10.1038/bmt.2010.249
- By:
- Publication type:
- Article
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.
- Published in:
- Bone Marrow Transplantation, 2011, v. 46, n. 8, p. 1053, doi. 10.1038/bmt.2010.264
- By:
- Publication type:
- Article
Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients.
- Published in:
- Bone Marrow Transplantation, 2010, v. 45, n. 2, p. 269, doi. 10.1038/bmt.2009.142
- By:
- Publication type:
- Article
Clinical applications of granulocyte colony-stimulating factor: an update and summary.
- Published in:
- Annals of Hematology, 2003, v. 82, n. 4, p. 207, doi. 10.1007/s00277-003-0628-y
- By:
- Publication type:
- Article
Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 94, n. 1, p. 150, doi. 10.1038/clpt.2013.58
- By:
- Publication type:
- Article
Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis.
- Published in:
- 2008
- By:
- Publication type:
- Letter
HIGH RATE OF METABOLIC COMPLETE RESPONSE AFTER LOW DOSE RADIOTHERAPY AND OBINUTUZUMAB IN EARLY STAGE FOLLICULAR LYMPHOMA: INITIAL RESULTS OF THE GAZAI STUDY (GLA 2018‐3).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 218, doi. 10.1002/hon.3163_142
- By:
- Publication type:
- Article
INMIND: A PHASE 3 STUDY OF TAFASITAMAB + LENALIDOMIDE AND RITUXIMAB VS PLACEBO + LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.175_2880
- By:
- Publication type:
- Article
ONGOING STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 571, doi. 10.1002/hon.19_2632
- By:
- Publication type:
- Article
AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION‐FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 43, doi. 10.1002/hon.13_2629
- By:
- Publication type:
- Article
ONGOING STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 571, doi. 10.1002/hon.19_2632
- By:
- Publication type:
- Article
AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION‐FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 43, doi. 10.1002/hon.13_2629
- By:
- Publication type:
- Article
Monoklonale Gammopathie unklarer Signifikanz und monoklonale B-Lymphozytose.
- Published in:
- Der Internist, 2013, v. 54, n. 6, p. 709, doi. 10.1007/s00108-012-3215-2
- By:
- Publication type:
- Article
Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis.
- Published in:
- 2006
- By:
- Publication type:
- Letter